Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

2.

eIF2B, a mediator of general and gene-specific translational control.

Pavitt GD.

Biochem Soc Trans. 2005 Dec;33(Pt 6):1487-92. Review.

PMID:
16246152
3.

The large spectrum of eIF2B-related diseases.

Fogli A, Boespflug-Tanguy O.

Biochem Soc Trans. 2006 Feb;34(Pt 1):22-9. Review.

PMID:
16246171
4.
5.

The spectrum of mutations for the diagnosis of vanishing white matter disease.

Scali O, Di Perri C, Federico A.

Neurol Sci. 2006 Sep;27(4):271-7. Review.

PMID:
16998732
6.

[Three-dimensional Structure of eIF2B: A Clue to Understanding the Pathogenesis of CACH/VWM Disease].

Kashiwagi K, Ito T, Yokoyama S.

Brain Nerve. 2017 Jan;69(1):45-50. doi: 10.11477/mf.1416200635. Review. Japanese.

PMID:
28126977
7.

Leukoencephalopathy with vanishing white matter: a review.

Bugiani M, Boor I, Powers JM, Scheper GC, van der Knaap MS.

J Neuropathol Exp Neurol. 2010 Oct;69(10):987-96. doi: 10.1097/NEN.0b013e3181f2eafa. Review.

PMID:
20838246
8.

[CACH/VWM syndrome and leucodystrophies related to EIF2B mutations].

Labauge P, Fogli A, Niel F, Rodriguez D, Boespflug-Tanguy O.

Rev Neurol (Paris). 2007 Sep;163(8-9):793-9. Review. French.

PMID:
17878805
9.

eIF2B: recent structural and functional insights into a key regulator of translation.

Wortham NC, Proud CG.

Biochem Soc Trans. 2015 Dec;43(6):1234-40. doi: 10.1042/BST20150164. Review.

PMID:
26614666
10.

A new function and complexity for protein translation initiation factor eIF2B.

Jennings MD, Pavitt GD.

Cell Cycle. 2014;13(17):2660-5. doi: 10.4161/15384101.2014.948797. Review.

11.

[Eukaryotic translation initiation factor 2B and leukoencephalopathy with vanishing white matter].

Pan YX, Wu Y, Niu ZP, Jiang YW.

Beijing Da Xue Xue Bao Yi Xue Ban. 2009 Oct 18;41(5):608-10. Review. Chinese.

12.

The latest on leukodystrophies.

Schiffmann R, van der Knaap MS.

Curr Opin Neurol. 2004 Apr;17(2):187-92. Review.

PMID:
15021247
13.

Localization of the translational guanine nucleotide exchange factor eIF2B: a common theme for GEFs?

Campbell SG, Ashe MP.

Cell Cycle. 2006 Apr;5(7):678-80. Epub 2006 Apr 1. Review.

PMID:
16582624
14.

Protein synthesis and its control in neuronal cells with a focus on vanishing white matter disease.

Pavitt GD, Proud CG.

Biochem Soc Trans. 2009 Dec;37(Pt 6):1298-310. doi: 10.1042/BST0371298. Review.

PMID:
19909266
15.

eIF2 and the control of cell physiology.

Proud CG.

Semin Cell Dev Biol. 2005 Feb;16(1):3-12. Epub 2004 Dec 10. Review.

PMID:
15659334
16.

Vanishing white matter disease.

van der Knaap MS, Pronk JC, Scheper GC.

Lancet Neurol. 2006 May;5(5):413-23. Review.

PMID:
16632312
17.

Clues to the mechanism of action of eIF2B, the guanine-nucleotide-exchange factor for translation initiation.

Mohammad-Qureshi SS, Jennings MD, Pavitt GD.

Biochem Soc Trans. 2008 Aug;36(Pt 4):658-64. doi: 10.1042/BST0360658. Review.

PMID:
18631136
18.

Multiple Sclerosis and EIF2B5: A Paradox or a Missing Link.

Zahoor I, Haq E, Asimi R.

Adv Exp Med Biol. 2017;958:57-64. doi: 10.1007/978-3-319-47861-6_5. Review.

PMID:
28093708
19.

Childhood Ataxia with Central Nervous System Hypomyelination/Vanishing White Matter.

Schiffmann R, Fogli A, van der Knaap MS, Boespflug-Tanguy O.

In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Mefford HC, Stephens K, Amemiya A, Ledbetter N, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2017.
2003 Feb 20 [updated 2012 Aug 9].

20.

eIF2B and oligodendrocyte survival: where nature and nurture meet in bipolar disorder and schizophrenia?

Carter CJ.

Schizophr Bull. 2007 Nov;33(6):1343-53. Epub 2007 Feb 27. Review.

Supplemental Content

Support Center